• Search History (Register)
  • MeSH Browser

Welcome to the international HTA database


Showing [25396 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2022     Health Sciences Institute in Aragon (IACS) [Digital dermatoscopy]
2020     Institute for Clinical Effectiveness and Health Policy (IECS) [Digital dermatoscopy for dysplastic nevi]
2022     Institute for Clinical Effectiveness and Health Policy (IECS) [Digital breast tomosynthesis]
2014     Institut national d'excellence en sante et en services sociaux (INESSS) [Digital Breast Tomosynthesis]
2026     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Diflunisal (hereditary transthyretin amyloidosis with polyneuropathy)]
2010     German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) [Differential diagnostic of the burnout syndrome]
2009     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Different antihypertensive drugs as first-line therapy in patients with essential hypertension]
2022     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Difelikefalin (pruritus) - Benefit assessment according to §35a Social Code Book V]
2013     The Swedish Council on Health Technology Assessment (SBU) [Dietary treatment of obesity]
2010     The Swedish Council on Health Technology Assessment (SBU) [Dietary treatment of diabetes]
2000     Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) [Dietary guidance in the primary health care sector (co-funded by DIHTA)]
2023     Institute for Clinical Effectiveness and Health Policy (IECS) [Dielectric radiofrequency for the treatment of primary hyperhidrosis and bromhidrosis]
2022     Institute for Clinical Effectiveness and Health Policy (IECS) [Diamine oxidase activity test for histamine intolerance]
2006     Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) [Dialysis in chronic renal failure - a health technology assessment]
2025     Swedish Agency for Health Technology Assessment and Assessment of Social Services (SBU) [Diagnostics of ovarian cancer; test accuracy of algorithm-based diagnostics in cases of suspected ovarian cancer]
2027     Swedish Agency for Health Technology Assessment and Assessment of Social Services (SBU) [Diagnostics of endometriosis]
2021     Swedish Agency for Health Technology Assessment and Assessment of Social Services (SBU) [Diagnostics and treatment of provoked vestibulodynia]
2010     The Netherlands Organisation for Health Research and Development (ZonMw) [Diagnostic value of novel biomarkers in patients with chest pain of suspected cardiac origin]
2008     The Netherlands Organisation for Health Research and Development (ZonMw) [Diagnostic value of an innovative non-invasive diagnostic to determine the grade of atherosclerosis before sternotomy in patients scheduled for cardiac surgery]
2014     National Evidence-based Healthcare Collaborating Agency (NECA) [Diagnostic usefulness of brain FDG-PET for Alzheimer's dementia]
2019     National Committee for Technology Incorporation (CONITEC) [Diagnostic tests for thrombophilia in pregnancy]
2002     Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) [Diagnostic radiology using transportable equipment]
2008     Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) [Diagnostic performance of techniques used for HER-2 testing in breast cancer]
2009     Andalusian Health Technology Assessment Area (AETSA) [Diagnostic performance of digital mammography in breast cancer screening]
2008     Andalusian Health Technology Assessment Area (AETSA) [Diagnostic performance of clinical prediction models for pulmonary embolism]
2014     The Swedish Council on Health Technology Assessment (SBU) [Diagnostic imaging in the staging of prostate cancer]
2014     The Swedish Council on Health Technology Assessment (SBU) [Diagnostic imaging in suspected prostate cancer]
2008     Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) [Diagnostic evaluation and treatment of dementia – a health technology assessment]
2005     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Diagnostic effectiveness, security and clinical usefulness of capsule endoscopy in the diagnosis of small bowel disorders]
2023     Agencia de Evaluacion de Tecnologias Sanitarias (AETS-ISCIII) [Diagnostic effectiveness of the determination of phosphorylated isoforms of tau protein (p-tau) in blood samples (plasma and/or serum) in Alzheimer’s disease]
2025     Agencia de Evaluacion de Tecnologias Sanitarias (AETS-ISCIII) [Diagnostic effectiveness of rapid immunochromatographic tests for the detection of Campylobacter spp. and Salmonella spp. in patients with acute gastroenteritis]
2018     Agencia de Evaluacion de Tecnologias Sanitarias (AETS-ISCIII) [Diagnostic effectiveness and safety of elastography in liver fibrosis]
2009     The Regional Health Technology Assessment Centre (HTA-centrum) [Diagnostic colon evaluation in patients with suspected colorectal neoplasia or at high risk of colorectal neoplasia - a comparison of double contrast barium enema (DCBE), CT colonography and colonoscopy]
2000     Basque Office for Health Technology Assessment (OSTEBA) [Diagnostic and therapeutic approach to non complex duodenal ulcer]
2024     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Diagnostic accuracy of impulse oscillometry (IOS) compared to spirometry]
2025     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Diagnostic accuracy of ex vivo confocal microscopy during Mohs surgery for basal cell carcinomas]
2026     Swedish Agency for Health Technology Assessment and Assessment of Social Services (SBU) [Diagnostic accuracy of different index-tests in diagnosing food allergy]
2027     Swedish Agency for Health Technology Assessment and Assessment of Social Services (SBU) [Diagnostic accuracy of different index tests in diagnosing suspected peanut allergy]
2012     National Evidence-based Healthcare Collaborating Agency (NECA) [Diagnostic accuracy of anti-CCP antibody test in rheumatoid arthritis: systematic review]
2025     Andalusian Health Technology Assessment Area (AETSA) [Diagnostic accuracy and safety of Point-of-Care UltraSound (POCUS) in internal medicine outpatients]
2004     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Diagnostic accuracy and clinical usefulness of Positron Emission Tomography (PET) in breast and ovarian cancer recurrence]
2023     Basque Office for Health Technology Assessment (OSTEBA) [Diagnosis of non-alcoholic fatty liver disease]
2014     Basque Office for Health Technology Assessment (OSTEBA) [Diagnosis of gestational diabetes mellitus: evaluation of the new IADPSG criteria]
2018     Swedish Agency for Health Technology Assessment and Assessment of Social Services (SBU) [Diagnosis and treatments for epilepsy – a systematic review]
2006     Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) [Diagnosis and treatment of obstructive sleep apnoea - a health technology assessment]
2012     Institut national d'excellence en sante et en services sociaux (INESSS) [Diagnosis and treatment of Chronic Cerebrospinal Venous Insufficiency (CCSVI) in people with Multiple Sclerosis (MS)]
2012     Institut national d'excellence en sante et en services sociaux (INESSS) [Diagnosis and treatment of chronic cerebrospinal venous insufficiency (CCSVI) for people with multiple sclerosis]
2013     The Swedish Council on Health Technology Assessment (SBU) [Diagnosis and treatment of ADHD and ASDs (autism spectrum disorders)]
2008     The Netherlands Organisation for Health Research and Development (ZonMw) [Diagnosis and staging of lung cancer by endoscopic ultrasound guided fine needle aspiration (EUS-FNA)]
2012     Basque Office for Health Technology Assessment (OSTEBA) [Diagnosis and consumption of drugs for Alzheimer's disease in the Basque country]
2011     Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) [Diabetic foot ulcers - a health technology assessment]
2025     Institut national d'excellence en sante et en services sociaux (INESSS) [Diabetic foot infection in adults: optimal use of antibiotic therapy and measures to prevent recurrence]
2022     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Developmental vision disorders: do children and adolescents benefit from active vision training?]
2017     Canary Health Service [Development of shared decision support tools derived from clinical practice guideline recommendations]
2020     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Development of scientific concepts for the generation of routine practice data and their analysis for the benefit assessment of drugs according to §35a Social Code Book V - rapid report]
2013     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Development of quality indicators for laser treatment for benign prostatic hyperplasia. Expert consensus]
2009     The Netherlands Organisation for Health Research and Development (ZonMw) [Development of organizational interventions to improve compliance with guidelines on depression and anxiety in primary care]
2010     Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) [Development of indicators to assess prevention programs for colorectal cancer in high risk populations]
2016     National Evidence-based Healthcare Collaborating Agency (NECA) [Development of evidence-based clinical imaging guidelines : to supply the evidence for appropriateness of diagnostic imaging studies and radiation exposure levels of patients]
2010     National Evidence-based Healthcare Collaborating Agency (NECA) [Development of empirical treatment guidelines in febrile neutropenic patients on the basis of the Korean data]
2009     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Development of decision-aid: HPV-patient information]
2009     Andalusian Health Technology Assessment Area (AETSA) [Development of criteria, complexity indicators and management strategies on frailty]
2014     Agencia de Evaluacion de Tecnologias Sanitarias (AETS-ISCIII) [Development of composite indicators to measure the quality of prevention and chronic management activities for gynecological cancer screening in primary care]
2014     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Development of appropriateness criteria for transcatheter aortic valve implantation (TAVI) for severe symptomatic aortic stenosis]
2009     Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) [Development of a shared knowledge system for network assessment of technological innovation in medicine]
2022     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Development of a scientific concept for the generation of routine practice data and their analysis for benefit assessments according to §35a Social Code Book (SGB) V in the event of market access for several drugs of one drug class]
2006     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Development of a prognosis model to identify effects of threshold values on health care]
2015     National Evidence-based Healthcare Collaborating Agency (NECA) [Development of a preference-based instrument: Asian Comparative Study]
2010     Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) [Development of a model for predicting emergency hospital admission and readmission in Catalonia]
2026     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Development of a general information sheet on outpatient psychotherapy for people with statutory health insurance]
2026     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Development of a decision aid for carotid revascularization surgery for carotid stenosis]
2025     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Development of a decision aid for aortic aneurysm interventions]
2011     Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) [Development of a basic set of expert consensus-based quality indicators for the care delivered to stroke patients]
2015     Institut national d'excellence en sante et en services sociaux (INESSS) [Development framework for social services practice guidelines]
2010     Unidad de Evaluacion de Tecnologias Sanitarias (UETS) [Development and validation of methods for quality assessment of health technologies assessments reports : assessment of ethical issues in health technologies assessment]
2008     Unidad de Evaluacion de Tecnologias Sanitarias (UETS) [Development and validation of methods for quality assessment of health technologies assessment reports]
2012     Unidad de Evaluacion de Tecnologias Sanitarias (UETS) [Development and validation of methods for quality assessment of health technologies assessment reports. Evaluation of the quality of qualitative studies]
2008     Basque Office for Health Technology Assessment (OSTEBA) [Development and evaluation of tools designed in order to ensure patient safety for possible incorporation into the management of healthcare processes]
2010     Canary Health Service [Development and evaluation of a decision support tool for benign prostatic hyperplasia patients]
2012     The Netherlands Organisation for Health Research and Development (ZonMw) [Development and application of clinical prediction models in the presence of multilevel data]
2025     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Deutivacaftor/tezacaftor/vanzacaftor (cystic fibrosis) - Assessment according to §35a (para. 1, sentence 11) Social Code Book V]
2026     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Deucravacitinib (psoriatic arthritis) – Benefit assessment according to §35a Social Code Book V]
2023     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Deucravacitinib (plaque psoriasis) – Benefit assessment according to §35a Social Code Book V]
2010     The Netherlands Organisation for Health Research and Development (ZonMw) [Determining optimal intervals for screening and surveillance: using individualized risk estimates to increase cost-effectiveness]
2019     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Determination of the SHI target population for the therapeutic indication type 2 diabetes mellitus using SHI routine data]
2014     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Determination of antigen expression levels of uPA and PAI-1 in primary breast cancer with intermediate recurrence risk after R0 primary surgery]
2023     Canary Health Service [Determination by chemiluminescence of autoantibodies to domain 1 of beta 2 glycoprotein I in patients with antiphospholipid syndrome]
2025     Institut national d'excellence en sante et en services sociaux (INESSS) [Detection of vancomycin-resistant enterococci (VRE)]
2013     Institute for Clinical Effectiveness and Health Policy (IECS) [Detection of sperm DNA fragmentation (TUNEL, SCSA, SCD, COMET) and use of annexin columns (MACS) in assisted reproduction treatments]
2024     Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS) [Detection of IDH1 mutations in cholangiocarcinoma patients]
2010     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Detection of high risk human papillomavirus E6 and E7 oncogenes for cervical cancer screening]
2014     Haute Autorite de sante (HAS) [Detection of enterovirus genome in cerebrospinal fluid by gene amplification in meningitis patients]
2015     Institut national d'excellence en sante et en services sociaux (INESSS) [Detection and diagnosis of Alzheimer's disease and other neurocognitive disorders]
2008     The Netherlands Organisation for Health Research and Development (ZonMw) [Detecting COPD in persons over 50 years with persistent cough in general practice: comparison of cost-effectiveness of diagnostic strategies]
2012     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [DETECTA-T]
2011     Health Intervention and Technology Assessment Program (HITAP) [Designing a decision frame for making health resource allocation decisions: a case study in Thailand]
2013     Basque Office for Health Technology Assessment (OSTEBA) [Design of an interaction protocol between Primary Care and Hospitals to improve early detection and monitoring of patients with multiple sclerosis]
2016     Basque Office for Health Technology Assessment (OSTEBA) [Design and validation of a screening tool for evaluating the health impact of regional policies]
2010     Basque Office for Health Technology Assessment (OSTEBA) [Design and implementation plan of telemedicine in specific clinical areas: telemonitoring and teledermatology. Assessment of initial results and costs]
2021     Center for Drug Evaluation (CDE) [Descriptive study and comparative effectiveness of listed medications for osteoporosis on new osteoporotic fracture event in osteoporosis patients by using National Health Insurance claim database]